Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial

Submitted by Fábio Marques ([email protected]) on 2018-10-11T17:27:05Z No. of bitstreams: 1 Differences in antiretroviral safety and efficacy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf: 611196 bytes, checksum: 8bf21e26149db5817e4ddd55425edf8d (MD5)Approved for entry into archive by Regina Costa ([email protected]) on 2018-10-15T13:13:47Z (GMT) No. of bitstreams: 1 Differences in antiretroviral safety and efficacy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf: 611196 bytes, checksum: 8bf21e26149db5817e4ddd55425edf8d (MD5)Made available in DSpace on 2018-10-15T13:13:47Z (GMT). No. of bitstreams: 1 Differences in antiretroviral safety and efficacy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf: 611196 bytes, checksum: 8bf21e26149db5817e4ddd55425edf8d (MD5) Previous issue date: 2015University of the Witwatersrand. Faculty of Health Sciences. Department of Internal Medicine. Johannesburg, South Africa./ Right to Care Johannesburg. South Africa.Harvard School of Public Health. Center for Biostatistics in AIDS Research. Boston, United States of America.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Durban University of technology. Durban, South Africa.University of the Witwatersrand. Faculty of Health Sciences. Department of Internal Medicine. Johannesburg, South Africa.University of Zimbabwe College of Health Sciences. Harare, Zimbabwe.IMPACTA Peru. San Miguel, PeruAlpert Medical School of Brown University. Providence, Rhode Island, United States of America.YRGCARE Medical Centre. Chennai, IndiaUniversity of Zimbabwe College of Health Sciences. Harare, Zimbabwe.University of Colorado School of Medicine. Department of Medicine. Division of Infectious Diseases. Aurora, United States of America.Worldwide, 50% of human immunodeficiency virus (HIV)-infected people are women. This study was to evaluate whether the safety and efficacy outcomes of three initial antiretroviral regimens (ARVs) differed by sex

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy : a multicountry open-label randomised controlled trial.

CAPRISA, 2016.Abstract available in PDF file